News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Bell John K
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2020 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 29 shares
@ $0 |
|
01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/21/2019 |
3
| Bell John K (Director) has filed a Form 3 on Cure Pharmaceutical Holding Corp. |
10/01/2019 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 29 shares
@ $0 |
|
09/19/2019 |
4/A
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Bought 35,000 shares
@ $0.6784, valued at
$23.7k
|
|
09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2019 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 29 shares
@ $0 |
|
05/01/2019 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Disposed/sold 200,000 rights
@ $0 |
|
04/01/2019 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 282 shares
@ $0.49, valued at
$138.2 |
|
01/02/2019 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 282 shares
@ $0.3419, valued at
$96.4 |
|
11/13/2018 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Granted 40,000 options to buy
@ $0.6099, valued at
$24.4k
|
|
10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/03/2018 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 282 shares
@ $3.2, valued at
$902.4 |
|
04/03/2018 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 282 shares
@ $3.2, valued at
$902.4 |
|
01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/17/2017 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Bought 1,871 shares
@ $0.81, valued at
$1.5k
Bought 18,129 shares
@ $0.81, valued at
$14.7k
|
|
10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/19/2016 |
4
| Bell John K (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns:
| Acquired 192 shares
@ $3.2, valued at
$614.4 |
|
05/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/02/2013 |
3/A
| Bell John K (Director) has filed a Form 3/A on DelMar Pharmaceuticals, Inc. |
02/20/2013 |
3
| Bell John K (Director) has filed a Form 3 on DelMar Pharmaceuticals, Inc. |
|
|